Pred-Gati-Brom is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Bromfenac Sodium; Prednisolone Acetate; Gatifloxacin.
| Product ID | 71384-503_638a351f-2b10-fd17-e053-2991aa0ae9a5 |
| NDC | 71384-503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pred-Gati-Brom |
| Generic Name | Prednisolone Acetate-gatifloxacin-bromfenac |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2018-01-12 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Imprimis NJOF, LLC |
| Substance Name | BROMFENAC SODIUM; PREDNISOLONE ACETATE; GATIFLOXACIN |
| Active Ingredient Strength | 1 mg/mL; mg/mL; mg/mL |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-01-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-01-12 |
| Marketing End Date | 2019-07-01 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-12 |
| Ingredient | Strength |
|---|---|
| BROMFENAC SODIUM | .75 mg/mL |
| SPL SET ID: | 6316c561-8cd1-fe74-e053-2991aa0aef5f |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70261-504 | Pred-Gati-Brom | Prednisolone-Gatifloxacin-Bromfenac |
| 71384-503 | Pred-Gati-Brom | Prednisolone Acetate-Gatifloxacin-Bromfenac |
| 71384-504 | Pred-Gati-Brom | Prednisolone Acetate-Gatifloxacin-Bromfenac |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PRED-GATI-BROM 87329328 5505056 Live/Registered |
HARROW IP, LLC 2017-02-08 |